Text Size

Internet-delivered Psychodynamic Therapy for Depression

This study has been completed.
Sponsor:
Information provided by:
Linkoeping University
ClinicalTrials.gov Identifier:
NCT01324050
First received: March 25, 2011
Last updated: August 1, 2011
Last verified: January 2011
History of Changes
  Purpose

The overall aim of this study is to develop and test a psychodynamic Internet-delivered psychological treatment for patients with mild to moderate major depression and compare its efficacy to an active control group.


Condition Intervention
Depression
 Behavioral: Internet-delivered psychodynamic therapy for depression
Behavioral: Internet-delivered therapist support

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Internet-delivered Psychodynamic Therapy for Depression: a Randomized Controlled Trial

Resource links provided by NLM:

MedlinePlus related topics: Anxiety Depression
U.S. FDA Resources

Further study details as provided by Linkoeping University:

Primary Outcome Measures:
  • Beck Depression Inventory (BDI) [ Time Frame: Two weeks before the treatment starts ]
  • Beck Depression Inventory (BDI) [ Time Frame: At treatment start (0 weeks) ]
  • Beck Depression Inventory (BDI) [ Time Frame: At treatment termination (10 weeks) ]

Secondary Outcome Measures:
  • Beck Anxiety Inventory (BAI) [ Time Frame: Two weeks before the treatment starts ]
  • Beck Anxiety Inventory (BAI) [ Time Frame: At treatment termination (10 weeks) ]
  • Montgomery Åsberg Depression Rating Scale Self-report (MADRS-S) [ Time Frame: Two weeks before treatment starts ]
  • Montgomery Åsberg Depression Rating Scale Self-report (MADRS-S) [ Time Frame: At treatment termination (10 weeks) ]
  • Quality of Life Inventory (QOLI) [ Time Frame: Two weeks before treatment starts ]
  • Quality of Life Inventory (QOLI) [ Time Frame: At treatment termination (10 weeks) ]
  • Patient Health Questionnaire 9 (PHQ-9) [ Time Frame: Two weeks before treatment starts ]
  • Patient Health Questionnaire 9 (PHQ-9) [ Time Frame: At treatment termination (10 weeks) ]
  • Generalised Anxiety Disorder Assessment 7 (GAD-7) [ Time Frame: Two weeks before treatment starts ]
  • Generalised Anxiety Disorder Assessment 7 (GAD-7) [ Time Frame: At treatment termination (10 weeks) ]

Enrollment: 92
Study Start Date: February 2011
Study Completion Date: May 2011
Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Internet-based Psychodynamic Therapy Behavioral: Internet-delivered psychodynamic therapy for depression
This intervention contains 9 text-based self-help modules. These modules contain material inspired by psychoanalytic theory about identifying reoccurring patterns in life among other things. In addition to the self-help modules, 10-15 minutes of therapist contact is given every week. In total, the intervention will last for 10 weeks.
Active Comparator: Internet-delivered therapist support Behavioral: Internet-delivered therapist support
This intervention contains 1 text-based self-help module, which is mainly based on information on depression. In addition to this text, the participants in this group gets 10-15 minutes of therapist contact every week. In the conversation with the therapist, the participant informs the therapist about the activities during the week. This intervention is considered to be a form of support. In total, the intervention will last for 10 weeks.

  Eligibility

Ages Eligible for Study:   18 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of Major Depressive Disorder
  • 15 or more on MADRS-S

Exclusion Criteria:

  • Severe depression (more than 35 on MADRS-S or based on interview)
  • Severe psychiatric condition (e.g. psychosis or bipolar disorder)
  • Suicidal (measured in diagnostic interview)
  • Changed medication during the last three months
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01324050

Locations
Sweden
Linköping University, Department of Behavioral Sciences and Learning
Linköping, Sweden
Linköping University
Linköping, Sweden
Sponsors and Collaborators
Linkoeping University
Investigators
Principal Investigator: Gerhard Andersson, PhD Department of Behavioral Sciences and Learning, Linköping University
  More Information

No publications provided by Linkoeping University

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Gerhard Andersson/Professor, Linkoeping University
ClinicalTrials.gov Identifier: NCT01324050     History of Changes
Other Study ID Numbers: GA-DEP2011-PDT
Study First Received: March 25, 2011
Last Updated: August 1, 2011
Health Authority: Sweden: Regional Ethical Review Board

Additional relevant MeSH terms:
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 16, 2013